pravastatin has been researched along with phenylephrine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Frohlich, BH; Gregg, RE; Tesfamariam, B | 1 |
| Granberry, MC; Kennedy, RH; Liu, H; Melchert, RB | 1 |
| Kassan, M; Montero, MJ; Sevilla, MA | 1 |
| Codoñer, MB; González-Santos, JM; Kassan, M; López-Rodríguez, J; Montero, MJ; Sevilla, MA; Sorlí, MJ | 1 |
5 other study(ies) available for pravastatin and phenylephrine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
Topics: Animals; Anticholesteremic Agents; Aorta; Atorvastatin; Calcium; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Drug Interactions; Fura-2; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mevalonic Acid; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Pravastatin; Pyrroles; Rats; Rats, Sprague-Dawley; Simvastatin; Vasoconstrictor Agents | 1999 |
Lovastatin inhibits phenylephrine-induced ERK activation and growth of cardiac.
Topics: Animals; Animals, Newborn; Anticholesteremic Agents; Blotting, Western; Cardiomegaly; Cells, Cultured; Coloring Agents; Enzyme Activation; Heart; Lovastatin; Mitogen-Activated Protein Kinases; Myocardium; Phenylephrine; Phosphorylation; Pravastatin; Propidium; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 2001 |
Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Male; Nitric Oxide; Nitroprusside; Oxidative Stress; Phenylephrine; Pravastatin; Rats; Rats, Inbred SHR; Superoxides | 2009 |
Pravastatin improves endothelial function in arteries used in coronary bypass grafting.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Aged; Coronary Artery Bypass; Coronary Artery Disease; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mammary Arteries; Nitroprusside; Phenylephrine; Postoperative Period; Pravastatin; Radial Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2013 |